Sinovac Biotech logo

SVA - Sinovac Biotech News Story

$6.47 0.0  0.0%

Last Trade - 22/02/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £189.2m
Position in Universe th / 6858

WHO sets dates for reviews of Sinopharm and Sinovac COVID-19 vaccines

Thu 22nd April, 2021 12:14pm
GENEVA, April 22 (Reuters) - Technical experts at the World
Health Organization (WHO) will review on April 26 Chinese
drugmaker Sinopharm's COVID-19 vaccine for possible emergency
use listing, to be followed by the Sinovac  SVA.O  jab on May 3,
the agency said on Thursday.
    "We would expect a decision a couple of days later," the WHO
said in response to a Reuters query.
     So far COVID-19 vaccines made by Pfizer  PFE.N  
AstraZeneca  AZN.L  and Johnson & Johnson  JNJ.N  have received
a WHO listing - an endorsement of their safety and efficacy that
helps to guide countries' regulatory agencies. 


    
    

 (Reporting by Stephanie Nebehay
Editing by David Goodman
)
 ((Stephanie.Nebehay@thomsonreuters.com; +41 58 306 2161;
Reuters Messaging:
stephanie.nebehay.thomsonreuters.com@reuters.net; twitter
@StephNebehay))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.